Literature DB >> 11683265

Tissue-specific isoforms of the ubiquitous transcription factor Oct-1.

E V Pankratova1, I E Deyev, S V Zhenilo, O L Polanovsky.   

Abstract

The ubiquitously expressed transcription factor Oct-1 is a member of the POU protein family. It is involved in the activation of snRNA promoters and some mRNA promoters (e.g., promoters and enhancers of genes for histone H2B and immunoglobulins). In this work we have cloned and sequenced a new Oct-1 isoform, named Oct-1L. Both Oct-1L mRNA and Oct-1R mRNA (cloned earlier) are expressed in lymphocytes, but not in any other cell line tested. This is the first report of tissue-specific Oct-1 gene expression. Both these forms differ from the ubiquitously expressed Oct-1 isoforms in the N-termini. They are probably generated by alternative splicing and/or alternative initiation of transcription. The latter is confirmed by the localization of transcription start points upstream of exons 1L (lymphocyte-specific) and IU (ubiquitously expressed). We assume that tissue-specific expression of Oct-1L and Oct-1R in lymphocytes and their structural differences from the ubiquitously expressed Oct-1 isoforms may be related to B and T cell differentiation and/or expression of the immunoglobulin genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683265     DOI: 10.1007/s004380100549

Source DB:  PubMed          Journal:  Mol Genet Genomics        ISSN: 1617-4623            Impact factor:   3.291


  12 in total

Review 1.  [Molecular-genetic mechanisms of developing the brain based on an embryonic Xenopus model].

Authors:  A G Zaraĭskiĭ
Journal:  Mol Biol (Mosk)       Date:  2004 Jan-Feb

2.  Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: an epigenome-wide association study.

Authors:  Scott M Langevin; Devin C Koestler; Brock C Christensen; Rondi A Butler; John K Wiencke; Heather H Nelson; E Andres Houseman; Carmen J Marsit; Karl T Kelsey
Journal:  Epigenetics       Date:  2012-03       Impact factor: 4.528

Review 3.  The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks.

Authors:  Karina Vázquez-Arreguín; Dean Tantin
Journal:  Biochim Biophys Acta       Date:  2016-02-10

4.  New alternative promoter in regulation of the Oct-1 human gene transcription.

Authors:  T N Portseva; I D Krylova; S G Georgieva; A G Stepchenko; E V Pankratova
Journal:  Dokl Biochem Biophys       Date:  2013-05-09       Impact factor: 0.788

5.  Involvement of transcription factor Oct-1 in the regulation of JAK-STAT signaling pathway in cells of Burkitt lymphoma.

Authors:  E V Pankratova; A G Stepchenko; I D Krylova; T N Portseva; S G Georgieva
Journal:  Dokl Biochem Biophys       Date:  2016-07-15       Impact factor: 0.788

6.  Embryonic lethality, decreased erythropoiesis, and defective octamer-dependent promoter activation in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Tara Schmidt; Jianzhu Chen; Phillip A Sharp; Dean Tantin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 7.  Octamer-binding transcription factors: genomics and functions.

Authors:  Feng-Qi Zhao
Journal:  Front Biosci (Landmark Ed)       Date:  2013-06-01

8.  Different N-terminal isoforms of Oct-1 control expression of distinct sets of genes and their high levels in Namalwa Burkitt's lymphoma cells affect a wide range of cellular processes.

Authors:  Elizaveta V Pankratova; Alexander G Stepchenko; Tatiana Portseva; Vladic A Mogila; Sofia G Georgieva
Journal:  Nucleic Acids Res       Date:  2016-07-12       Impact factor: 16.971

9.  GSK3 Kinase Inhibitor, CHIR, Suppress Transcription of Tissue Specific POU2F1 Isoform in Burkitt Namalwa Lymphoma Cells.

Authors:  E V Pankratova; T N Portseva; A A Makarova; Yu V Ilyin; A G Stepchenko; S G Georgieva
Journal:  Dokl Biochem Biophys       Date:  2021-03-10       Impact factor: 0.788

10.  The regulatory interplay between Oct-1 isoforms contributes to hematopoiesis and the isoforms imbalance correlates with a malignant transformation of B cells.

Authors:  Elizaveta V Pankratova; Alexander G Stepchenko; Irina D Krylova; Tatiana N Portseva; Sofia G Georgieva
Journal:  Oncotarget       Date:  2018-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.